How can startup leaders support long-term sustainable growth and investment?
BioSpace’s Lori Ellis speaks with venture capital guests Ansbert Gadicke, Martin Gershon and Mike Goguen for their advice and recommendations on how biopharma startups should approach funding.
 
Host 
<a href="https://www.linkedin.com/in/lorielliskatz/">⁠⁠⁠⁠⁠Lori Ellis⁠⁠⁠⁠⁠</a>, Head of Insights, BioSpace  
 
Guests
<a href="https://www.linkedin.com/in/ansbert-gadicke-m-d-2437b5/">⁠Ansbert Gadicke⁠</a>, Managing Director, MPM Capital
<a href="https://www.linkedin.com/in/martingershon/">⁠Martin Gershon⁠</a>, Managing Partner &amp; CIO, Endeavor Venture Fund
<a href="https://www.linkedin.com/in/michael-goguen-23314/">⁠Mike Goguen⁠</a>, Founder and Managing Partner, Two Bear Capital

The top life sciences startups to watch this year

Unravel the business of science with BioSpace. We dive into biopharma's top stories and biggest challenges, whether it’s layoffs, pipeline shake-ups, acquisitions, new FDA approvals or how to regulate AI in drug development.